S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
2 Important Retail Stock Battles to Watch
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
Closing prices for crude oil, gold and other commodities
Pipeline break spills 45,000 gallons of diesel in Wyoming
Sinema took Wall Street money while killing tax on investors
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
MarketBeat: Week in Review 8/8 - 8/12
Expanded IRS free-file system one step closer in Dems' bill
In Biden's big bill: Climate, health care, deficit reduction
The Day of Financial Reckoning Is Near (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
2 Important Retail Stock Battles to Watch
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
Closing prices for crude oil, gold and other commodities
Pipeline break spills 45,000 gallons of diesel in Wyoming
Sinema took Wall Street money while killing tax on investors
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
MarketBeat: Week in Review 8/8 - 8/12
Expanded IRS free-file system one step closer in Dems' bill
In Biden's big bill: Climate, health care, deficit reduction
The Day of Financial Reckoning Is Near (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
2 Important Retail Stock Battles to Watch
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
Closing prices for crude oil, gold and other commodities
Pipeline break spills 45,000 gallons of diesel in Wyoming
Sinema took Wall Street money while killing tax on investors
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
MarketBeat: Week in Review 8/8 - 8/12
Expanded IRS free-file system one step closer in Dems' bill
In Biden's big bill: Climate, health care, deficit reduction
The Day of Financial Reckoning Is Near (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
2 Important Retail Stock Battles to Watch
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
Closing prices for crude oil, gold and other commodities
Pipeline break spills 45,000 gallons of diesel in Wyoming
Sinema took Wall Street money while killing tax on investors
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
MarketBeat: Week in Review 8/8 - 8/12
Expanded IRS free-file system one step closer in Dems' bill
In Biden's big bill: Climate, health care, deficit reduction
The Day of Financial Reckoning Is Near (Ad)
OTCMKTS:RDSMY

Koninklijke DSM - RDSMY Stock Forecast, Price & News

$37.91
+0.76 (+2.05%)
(As of 08/12/2022 12:00 AM ET)
Add
Compare
Today's Range
$37.34
$37.91
50-Day Range
$34.47
$41.76
52-Week Range
$34.13
$56.92
Volume
80,313 shs
Average Volume
43,307 shs
Market Capitalization
$26.50 billion
P/E Ratio
N/A
Dividend Yield
1.03%
Price Target
$174.00

Koninklijke DSM MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
359.0% Upside
$174.00 Price Target
Short Interest
Healthy
0.00% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
0.85%
From $1.18 to $1.19 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.86 out of 5 stars

RDSMY stock logo

About Koninklijke DSM (OTCMKTS:RDSMY) Stock

Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, premixes, carotenoids, enzymes, microbes, and eubiotics; human nutrition and health products comprising vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics, and prebiotics, as well as active pharmaceutical ingredients; premix, market-ready solutions, and personalized nutrition; human milk oligosaccharides; and skin and sun care, hair care, and aroma ingredients; omega-3 fatty acids; and specialty food enzymes, cultures, bio-preservation, texturizing hydrocolloids, sugar reduction, and savory taste solutions. The Materials segment provides specialty plastics used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries; and Dyneema, a fiber solution for use in personal protection, workwear, sports apparel, outdoor equipment, ropes and slings, synthetic chains, and nets for the aquaculture, and renewable energy sectors. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, continence care, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, peripheral vascular, plastic and reconstructive surgery, and wound management. It also commercializes yeast technology yeast for ethanol production. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands.

Receive RDSMY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Koninklijke DSM and its competitors with MarketBeat's FREE daily newsletter.

RDSMY Stock News Headlines

Koninklijke DSM Earnings, Revenue Miss in Q2
DSM reports H1 2022 results
Analysts Set Koninklijke DSM (OTCMKTS:RDSMY) PT at $174.00
Update on public exchange offer process
Royal DSM to merge with Firmenich
DSM NV: Staying Resilient Through The Downcycle
DSM announces final dividend for 2021
DSM - repurchase of shares (2-6 May 2022)
DSM - repurchase of shares (25-29 April 2022)
DSM announces sale of Protective Materials business
DSM - repurchase of shares (11-15 April 2022)
DSM - repurchase of shares (4-8 April 2022)
DSM - repurchase of shares (28 March-1 April 2022)
DSM provides preliminary 2021 comparative figures
DSM - repurchase of shares (21-25 March 2022)
DSM - repurchase of shares (14-18 March 2022)
DSM - repurchase of shares (10-11 March 2022)
See More Headlines
Receive RDSMY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Koninklijke DSM and its competitors with MarketBeat's FREE daily newsletter.

RDSMY Company Calendar

Last Earnings
11/03/2020
Ex-Dividend for 6/10 Dividend
5/13/2022
Dividend Payable
6/10/2022
Ex-Dividend for 9/2 Dividend
8/11/2022
Today
8/13/2022
Dividend Payable
9/02/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Chemicals & allied products
Sub-Industry
N/A
Current Symbol
OTCMKTS:RDSMY
Previous Symbol
NASDAQ:RDSMY
Employees
21,358
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$174.00
High Stock Price Forecast
$188.00
Low Stock Price Forecast
$155.00
Forecasted Upside/Downside
+359.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
10 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$10.89 billion
Cash Flow
$2.33 per share
Book Value
$11.78 per share

Miscellaneous

Free Float
N/A
Market Cap
$26.50 billion
Optionable
Not Optionable
Beta
0.96

Key Executives

  • Mr. Dimitri de Vreeze (Age 55)
    Co-CEO, COO & Member of the Managing Board
    Comp: $2.07M
  • Ms. Geraldine Matchett (Age 50)
    Co-CEO, CFO, Member of the Managing Board & Acting EVP of People & Organization
    Comp: $2.02M
  • Mr. Dave Huizing
    VP of Investor Relations
  • Ms. Lieke de Jong-Tops
    Sr. Communications Mang.
  • Mr. Rob J. Atsma (Age 76)
    Head of Energie Beheer Nederland
  • Mr. Paul Gilgen (Age 77)
    Head of Manufacturing & Purchasing of DSM Nutritional Products
  • Mr. Manfred Eggersdorfer (Age 71)
    Sr. VP of Nutrition Science & Advocacy
  • Mr. Bruno Müller (Age 66)
    Head of Strategy & VITAL Project - Nutritional Products
  • Mr. Jan Wolters (Age 79)
    Head of Fine Chemicals
  • Mr. Luca Rosetto (Age 59)
    Sr. VP of Operations - Nutritional Products













RDSMY Stock - Frequently Asked Questions

Should I buy or sell Koninklijke DSM stock right now?

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Koninklijke DSM in the last twelve months. There are currently 2 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" RDSMY shares.
View RDSMY analyst ratings
or view top-rated stocks.

What is Koninklijke DSM's stock price forecast for 2022?

10 Wall Street research analysts have issued 12 month target prices for Koninklijke DSM's stock. Their RDSMY share price forecasts range from $155.00 to $188.00. On average, they expect the company's share price to reach $174.00 in the next year. This suggests a possible upside of 359.0% from the stock's current price.
View analysts price targets for RDSMY
or view top-rated stocks among Wall Street analysts.

How have RDSMY shares performed in 2022?

Koninklijke DSM's stock was trading at $56.61 at the beginning of 2022. Since then, RDSMY stock has decreased by 33.0% and is now trading at $37.91.
View the best growth stocks for 2022 here
.

Are investors shorting Koninklijke DSM?

Koninklijke DSM saw a increase in short interest during the month of July. As of July 31st, there was short interest totaling 17,400 shares, an increase of 31.8% from the July 15th total of 13,200 shares. Based on an average daily volume of 95,900 shares, the short-interest ratio is presently 0.2 days.
View Koninklijke DSM's Short Interest
.

How were Koninklijke DSM's earnings last quarter?

Koninklijke DSM (OTCMKTS:RDSMY) released its quarterly earnings data on Tuesday, November, 3rd. The basic materials company reported $0.30 EPS for the quarter, missing analysts' consensus estimates of $0.31 by $0.01. The basic materials company had revenue of $2.29 billion for the quarter.
Read the conference call transcript
.

How often does Koninklijke DSM pay dividends? What is the dividend yield for Koninklijke DSM?

Koninklijke DSM declared a dividend on Saturday, August 6th. Stockholders of record on Friday, August 12th will be paid a dividend of $0.1906 per share on Friday, September 2nd. This represents a yield of 1.52%. The ex-dividend date of this dividend is Thursday, August 11th.
Read our dividend analysis for RDSMY
.

Is Koninklijke DSM a good dividend stock?

Koninklijke DSM (OTCMKTS:RDSMY) pays an annual dividend of $0.38 per share and currently has a dividend yield of 1.03%.
Read our dividend analysis for RDSMY.

What is Koninklijke DSM's stock symbol?

Koninklijke DSM trades on the OTCMKTS under the ticker symbol "RDSMY."

How do I buy shares of Koninklijke DSM?

Shares of RDSMY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Koninklijke DSM's stock price today?

One share of RDSMY stock can currently be purchased for approximately $37.91.

How much money does Koninklijke DSM make?

Koninklijke DSM (OTCMKTS:RDSMY) has a market capitalization of $26.50 billion and generates $10.89 billion in revenue each year.

How many employees does Koninklijke DSM have?

The company employs 21,358 workers across the globe.

How can I contact Koninklijke DSM?

Koninklijke DSM's mailing address is Het Overloon 1, Heerlrn P7, 6411 TE. The official website for the company is www.dsm.com. The basic materials company can be reached via phone at (145) 578-8111 or via fax at 31-45-571-9753.

This page (OTCMKTS:RDSMY) was last updated on 8/13/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.